Li Tianhong, Qin Xinfang, Wei Lili, Bi Huixin
Department of Nephrology, First Affiliated Hospital of Guilin Medical University, Guilin 541000, China.
Department of Nephrology, Fifth Affiliated Hospital of Southern Medical University, Guangzhou 510999, China.
Nan Fang Yi Ke Da Xue Xue Bao. 2025 Aug 20;45(8):1663-1671. doi: 10.12122/j.issn.1673-4254.2025.08.11.
To investigate the effect of serum advanced glycation endproducts (AGEs) on stenosis after first autologous arteriovenous fistula (AVF) in patients with end-stage renal disease (ESRD).
Patients with ESRD undergoing standard native arteriovenous fistula (AVF) for the first time in the Department of Nephrology, Affiliated Hospital of Guilin Medical University from February to June 2022 were prospectively enrolled. The preoperative general data, clinical examination results and ultrasound data of the operated limbs were collected. The patients with and without stenosis within 2 months after the operation were compared for preoperative serum AGEs levels detected using ELISA and the clinical parameters. Logistic regression analysis was used to analyze the independent risk factors of AVF stenosis, and the sensitivity and specificity of AGEs for predicting postoperative stenosis were analyzed using receiver-operating characteristic (ROC) curve.
Of the 94 patients enrolled, 34 had postoperative arteriovenous stenosis and 60 had no stenosis. The number of diabetic patients differed significantly between stenosis group and non-stenosis group (<0.001). Serum AGEs levels, which were negatively correlated with serum phosphorus level (<0.05), were significantly higher in stenosis group than in non-stenosis group (=-2.837, =0.005). Serum AGE level was an independent risk factor for postoperative stenosis after AVF (OR=1.251, 95% :1.096-1.423, <0.001). For predicting AVF stenosis, the area under the ROC curve (AUC) of AGEs was 0.677 (=0.007, 95% : 0.572-0.770), with a specificity of 90.00% and a sensitivity of 52.94% at the optimal cut-off value of 8.43 µg/mL; AGEs combined with fibrinogen had an AUC of 0.763 (<0.001, 95% : 0.664-0.844), with a specificity of 73.33% and a sensitivity of 70.59% at the optimal cut-off value of 0.30.
Elevated serum AGEs level is an independent risk factor for postoperative AVF stenosis, and its combination with fibrinogen has a better efficacy for predicting postoperative AVF stenosis.
探讨血清晚期糖基化终末产物(AGEs)对终末期肾病(ESRD)患者首次自体动静脉内瘘(AVF)术后狭窄的影响。
前瞻性纳入2022年2月至6月在桂林医学院附属医院肾内科首次接受标准自体动静脉内瘘(AVF)手术的ESRD患者。收集术前一般资料、临床检查结果及手术肢体的超声数据。比较术后2个月内发生狭窄和未发生狭窄患者术前采用酶联免疫吸附测定法(ELISA)检测的血清AGEs水平及临床参数。采用Logistic回归分析分析AVF狭窄的独立危险因素,并用受试者工作特征(ROC)曲线分析AGEs预测术后狭窄的敏感性和特异性。
纳入的94例患者中,34例术后发生动静脉狭窄,60例未发生狭窄。狭窄组和非狭窄组糖尿病患者数量差异有统计学意义(<0.001)。血清AGEs水平与血清磷水平呈负相关(<0.05),狭窄组血清AGEs水平显著高于非狭窄组(=-2.837,=0.005)。血清AGE水平是AVF术后狭窄的独立危险因素(OR=1.251,95%:1.096-1.423,<0.001)。对于预测AVF狭窄,AGEs的ROC曲线下面积(AUC)为0.677(=0.007,95%:0.572-0.770),在最佳截断值为8.43µg/mL时,特异性为90.00%,敏感性为52.94%;AGEs与纤维蛋白原联合检测的AUC为0.763(<0.001,95%:0.664-0.844),在最佳截断值为0.30时,特异性为73.33%,敏感性为70.59%。
血清AGEs水平升高是AVF术后狭窄的独立危险因素,其与纤维蛋白原联合检测对预测AVF术后狭窄有更好的效能。